Topigen Pharmaceuticals Inc. Report issue

For profit Phase 1 Phase 2
Founded: Montreal Canada (2000)
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2008
NCT00550797
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Topigen Pharmaceuticals, Montreal, Quebec/Canada

Active Ingredients

Drugs in Phase 2 Trials (1)

tpi asm8 (2 trials)

Drugs in Phase 1 Trials (1)

tpi 1100 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Asthma (Phase 2)

Lung Diseases, Obstructive (Phase 1)

Pulmonary Disease, Chronic Obstructive (Phase 1)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 2